Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2021–2024 · grant · Standard Grant
Collaborative Research: Covariate-Driven Approaches to Network Estimation
Christine Peterson · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2021–2026 · research · R00
Functional characterization of novel oncogenic loci driving progression and immune response in gastrointestinal cancer
Yuan-Hung Lo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2025 · research · R21
Targeted Hyperpolarized Molecular Beacons for Colorectal Cancer Detection
Pratip K. Bhattacharya · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Fgl2 neutralizing therapy for inducing tumor specific brain resident immune memory against CNS tumor relapse
Amy Beth Heimberger · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Statistical Modeling of Alzheimer's Disease Progression Integrating Brain Imaging and -Omics Data
Suprateek Kundu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · research · R21
Contribution of Epigenome to PRKCI-Driven High-Grade Serous Ovarian Cancer
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021 · grant · Academic Research
Early Clinical Investigator
Carl Gay · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2021 · career development · Young Investigator Award
Cross-sectional Study of the Association Between Discrimination, Trust, and Pain Outcomes Among Black Women with Early Stage Breast Cancer After Mastectomy
Demetria Smith-Graziani · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2021–2026 · research · R01
Radiomic and genomic predictors of breast cancer risk
Laurel A Habel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2024 · research · R21
Role of β-lactamase encoding gene amplification in the development of non-carbapenemase producing, carbapenem-resistant Enterobacteriaceae
Samuel A Shelburne · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Fgl2 neutralizing therapy for inducing tumor specific brain resident immune memory against CNS tumor relapse
Amy Beth Heimberger · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Cancer Immune-Interception for Lynch Syndrome
Steven M Lipkin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
Ferdinandos Skoulidis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Targeting replication stress and homologous recombination repair mechanisms in HPV-positive and negative head and neck cancer
Mitchell J. Frederick · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · career development · K99
Mechanisms of translational output control in pancreatic cancer
Simone Christine Hausmann · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
Wen Jiang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Analyzing the Endothelial Cell-Expressed Prion Gene Prnd in Vascular Development
Joseph H Mccarty · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · research · R56
Regulation and function of nonlymphoid organ CD103+ dendritic cells
Stephanie S Watowich · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R50
Targeting EGFR mutant tyrosine kinase inhibitors (TKIs) resistant and drug-tolerant persister cells in non-small cell lung cancer (NSCLC)
Monique B Nilsson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
Timothy Anthony Yap · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2024 · research · R01
Effects of biologic and targeted therapies for rheumatoid arthritis on cancer outcomes
Sharon Hermes Giordano · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2024 · research · R01
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device
John Paul Christodouleas · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · research · R03
Impact of diagnostic peritoneal lavage on omentum metastasis
Honami Naora · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2025 · research · R01
Integrative Brain Network-Based Analysis for Heterogeneous and Multimodal
Suprateek Kundu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · award
Health Benefits of Writing Therapy among Chinese Breast Cancer Survivors
Qian Lu · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2021–2026 · research · R01
Mechanisms associated with organotropic metastasis
Raghu Kalluri · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021 · grant · Academic Research
Early Clinical Investigator
Moran Amit · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2021–2026 · research · R01
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
Timothy Anthony Yap · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer
Humam Kadara · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer
Min Sup Song · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021 · grant · Academic Research
The Future of Cancer Research: Training Program for Basic and Translational Scientists
Khandan Keyomarsi · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2021–2026 · research · R01
Elucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2
Jonathan M Kurie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2025 · research · R21
Impact of regulatory cross-talk on the pathophysiology of emergent acapsular group A streptococcus
Samuel A Shelburne · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Transcriptomic mechanisms underlying the immune modulating function and therapeutic efficacy of PARP inhibitors
Timothy Anthony Yap · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021 · grant · Prevention
Taking Texas Tobacco Free: Dissemination to and Implementation within Agencies Serving Texans Experiencing Homelessness
Lorraine Reitzel · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2021–2026 · research · R01
RNase H2 is a novel therapeutic target in triple negative breast cancer
Shiaw-Yih Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021–2023 · research · R21
Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma
Michael Richard Green · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2021 · grant · Prevention
Strengthening Safety Net Health Systems to Improve Cervical and Colorectal Cancer Screening and Follow-up among the Medically Underserved
Jane R Montealegre · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2021–2025 · award
Liver tumor immune environment: imaging and modulation after therapy
Rony Avritscher · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2021–2026 · research · R01
Neutrophil Extracellular Traps and Host Immunity
Jyotika Sharma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
